Your browser doesn't support javascript.
loading
Early phase clinical trial played a critical role in the Food and Drug Administration-approved indications for targeted anticancer drugs: a cross-sectional study from 2012 to 2021.
Huang, Yafang; Xiong, Weiyi; Zhao, Jingwei; Li, Wentao; Ma, Li; Wu, Hao.
Afiliação
  • Huang Y; School of General Practice and Continuing Education, Capital Medical University, Beijing, China. Electronic address: yafang@ccmu.edu.cn.
  • Xiong W; Department II of Pharmaceuticals Surveillance and Evaluation, National Center for ADR monitoring, Beijing, China.
  • Zhao J; School of General Practice and Continuing Education, Capital Medical University, Beijing, China.
  • Li W; School of General Practice and Continuing Education, Capital Medical University, Beijing, China.
  • Ma L; Department of General Practice, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  • Wu H; School of General Practice and Continuing Education, Capital Medical University, Beijing, China. Electronic address: wushunzhe@ccmu.edu.cn.
J Clin Epidemiol ; 157: 74-82, 2023 05.
Article em En | MEDLINE | ID: mdl-36905971

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Aprovação de Drogas / Antineoplásicos Tipo de estudo: Clinical_trials / Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: J Clin Epidemiol Assunto da revista: EPIDEMIOLOGIA Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Aprovação de Drogas / Antineoplásicos Tipo de estudo: Clinical_trials / Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: J Clin Epidemiol Assunto da revista: EPIDEMIOLOGIA Ano de publicação: 2023 Tipo de documento: Article